Biocon Ltd.'s disappointing Q3FY25 performance was largely due to exceptional items, with adjusted net profit standing at Rs 13 crore, and revenue growth of 7% on a like-for-like basis.

Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical ... As Resonant Link Medical, it will be solely focused on expanding its trusted... at 06:30 Asia Book of ...

New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital reached new heights in cardiovascular care when they performed the state's and the system's first ...

Cipla's shares are currently priced at Rs 1439.65, reflecting a modest rise of 0.82%. The 7-day simple moving average is Rs 1475.93. Cipla is currently valued at Rs 1437.65, with a daily increase of 0 ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the manufacturing facility of Medispray Laboratories Private Limited, a wholly ...

Net sales soared 281.1% to Rs 161.76 crore in Q3 FY25 as compared with Rs 42.45 crore posted in corresponding quarter last year. Cipla said the United States Food and Drug Administration (USFDA) ...

However, Wall Street's enthusiasm for Summit Therapeutics appears to be justified. If ivonescimab fulfills its potential, Summit should be worth a lot more within a few years than it is today.

The United States Food and Drug Administration (USFDA) conducted an inspection at the manufacturing facility of the company’s subsidiary, Medispray Laboratories, in Goa, from January 14 to 20 ...

Pharma major Cipla Ltd on Monday (January 20) announced that the United States Food and Drug Administration (FDA) conducted an inspection of its wholly-owned subsidiary, Medispray Laboratories Private ...